Executive record
Jonathan Poole
Most recent record: Vertex Pharmaceuticals Incorporated CFO transition: Jonathan Poole to succeed Charles F. Wagner, Jr. (named as the incoming officer), effective January 1, 2027. See Vertex Pharmaceuticals Incorporated.
1 verified record
This page lists only verified filing records that name Jonathan Poole; it is not a career history. Corrections: the corrections page.